OFFICIAL PUBLICATION OF

by its subsidiary APPco

New combo therapy to be listed

Sheshtyn Paola 26/03/2018

pharmacist pharmacy medicines meds pills

A new combination therapy for type 2 diabetes, which can be prescribed alongside metformin, is set to be listed on the PBS from 1 April Glyxambi, a new oral, fixed-dose combination of the SGLT2 empagliflozin inhibitor (Jardiance) and DPP4 inhibitor linagliptin (Trajenta) will become available on the PBS from 1 April 2018. Glyxambi (empagliflozin/linagliptin) can

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Fair pay for full scope: union

Agreed, sad that the profession is so cheap thanks to discounting. I can understand the Guild's logic in supporting this,…

Morbidly Obese John

TGA withdraws InstantScripts infringement notices

We got an email at work last week offering 20% off services. I suspect it's not illegal to offer a…

Philip Smith

‘Force in cardiology’ lauded

Congrats Adam, so well deserved, and a top bloke as well.

Stephen Roberts

What’s next in health for the federal government?

James. Your experience with real pharmacy problems is spot on. The core pharmaceutical manufacturing base in Australia has diminished over…

Silas (Si) Banks

New combo therapy to be listed

Previous Recognising service on transfer of business

Next Blockbuster alert

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Recognising service on transfer of business

Next Blockbuster alert

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.